Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Other Accumulated Expenses (2014 - 2025)

Pro Dex recorded quarterly Other Accumulated Expenses of $229000.0 in Q2 2025, up 21.16% quarter-over-quarter from $189000.0 in Q2 2024, and up 21.16% year-over-year from $189000.0 in Q2 2024.

Pro Dex's Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $229000.0 for Q2 2025.

  • In Q2 2025, Other Accumulated Expenses rose 21.16% year-over-year to $229000.0; the TTM figure through Jun 2025 stood at $229000.0 (up 21.16% YoY), while the FY2025 annual figure was $229000.0, up 21.16% from the prior year.
  • Other Accumulated Expenses came in at $229000.0 for Q2 2025 at Pro Dex, up from $189000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $229000.0 in Q2 2025 to a low of $124000.0 in Q2 2022.
  • A 5-year average of $172000.0 and a median of $182000.0 in 2021 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses sank 31.87% in 2022 and surged 38.97% in 2024, its largest moves.
  • Pro Dex's Other Accumulated Expenses stood at $182000.0 in 2021, then tumbled by 31.87% to $124000.0 in 2022, then grew by 9.68% to $136000.0 in 2023, then soared by 38.97% to $189000.0 in 2024, then climbed by 21.16% to $229000.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $229000.0, $189000.0, and $136000.0 for Q2 2025, Q2 2024, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Pro Dex 201.21 Mn 193.60 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 229,000.00
Jun 30, 2024 189,000.00
Jun 30, 2023 136,000.00
Jun 30, 2022 124,000.00
Jun 30, 2021 182,000.00
Jun 30, 2020 149,000.00
Jun 30, 2016 83,000.00
Jun 30, 2015 89,000.00
Jun 30, 2014 102,000.00